Roger Hanselmann

This inventor holds 14 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Melinta Therapeutics, Inc., Rib-X Pharmaceuticals, Inc., Akebia Therapeutics, Inc.. Active years: 2005-2018.

USPTO Granted Patents = 14 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 60(Granted Patents)

Company Filing History:

6 out of 24

Melinta Therapeutics, Inc.

patents

6 out of 17

Rib-X Pharmaceuticals, Inc.

patents

1 out of 37

Akebia Therapeutics, Inc.

patents

4. 1 out of 834,411

Other

patents

Years Active: 2005-2018

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10150734 - Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof (2018-12-11),

2. RE46617 - Process for making quinolone compounds (2017-11-27),

3. 9550783 - Biaryl heterocyclic compounds and methods of making and using the same (2017-01-24),

4. 9376400 - Process for the synthesis of triazoles (2016-06-28),

5. 8895741 - Process for the synthesis of biaryl oxazolidinones (2014-11-25),

6. 8871938 - Process for making quinolone compounds (2014-10-28),

7. 8796465 - Process for the syntheses of triazoles (2014-08-05),

8. 8497378 - Process for making quinolone compounds (2013-07-30),

9. 8399660 - Process for the synthesis of triazoles (2013-03-19),

10. 8324398 - Process for the synthesis of biaryl oxazolidinones (2012-12-04),

11. 7705026 - Biaryl heterocyclic compounds and methods of making and using the same (2010-04-27),

12. 7456206 - Biaryl heterocyclic compounds and methods of making and using the same (2008-11-25),

13. 7148219 - Biaryl heterocyclic compounds and methods of making and using the same (2006-12-12),

14. 6969726 - Biaryl heterocyclic compounds and methods of making and using the same (2005-11-29),

Title: Roger Hanselmann: A Pioneer in Pharmaceutical Innovation

Introduction

Roger Hanselmann is an accomplished inventor based in Branford, CT, with a remarkable portfolio of 14 patents. His contributions to the field of pharmaceutical research and development have paved the way for innovative treatments targeting various diseases and disorders. Hanselmann's work exemplifies the intersection of chemistry and medicine, showcasing the impact of well-conceived inventions in health care.

Latest Patents

Among his latest notable patents is the development of solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid. This patent focuses on solid forms that comprise this compound, along with methods for preparing these forms and their applications in the treatment of numerous diseases and disorders. Additionally, Hanselmann has patented a process for making quinolone compounds, a significant advancement in synthesizing anti-infective agents. This invention emphasizes the efficiency of production, yielding a minimal percentage of dimeric impurity, thereby enhancing the safety and effectiveness of these compounds.

Career Highlights

Roger Hanselmann has been associated with prominent companies in the pharmaceutical industry, including Rib-X Pharmaceuticals and Melinta Therapeutics. At these organizations, he has contributed to developing innovative therapeutic solutions that address critical health issues. His role has significantly influenced the creation and optimization of drug candidates in both companies, underscoring his expertise in pharmaceutical sciences.

Collaborations

Throughout his career, Hanselmann has collaborated with skilled professionals, including Rongliang Lou and Jiacheng Zhou. These partnerships have fostered a productive environment for innovation, allowing for the exchange of ideas and the development of cutting-edge pharmaceutical products.

Conclusion

Roger Hanselmann's inventive contributions and his impactful career in pharmaceutical innovation continue to drive advancements in healthcare. His dedication to synthesizing new compounds and improving treatments epitomizes the spirit of invention necessary for overcoming health challenges. With his impressive collection of patents, Hanselmann remains a vital figure in the realm of pharmaceutical research and development.